Clinical Trials Directory

Trials / Completed

CompletedNCT05958589

Caudal Block for Inguinal Hernioplasty in Children

Efficacy and Safety of General Anesthesia With Caudal Block for Inguinal Hernioplasty in Children: a Randomized Controlled Trial

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
70 (actual)
Sponsor
University of Novi Sad · Academic / Other
Sex
Male
Age
3 Years – 5 Years
Healthy volunteers
Not accepted

Summary

This is a prospective, randomized, controlled clinical study designed to determine the effectiveness of caudal block combined with general anesthesia in providing intra- and postoperative analgesia, and its effect on hemodynamic stability and drug consumption.

Detailed description

This prospective, randomized, controlled clinical study will include 70 boys aged 3-5 years scheduled for inguinal herniorrhaphy. Participants will be randomized in 1:1 ratio into two groups. The first group will receive general anesthesia for surgery, while the second group will receive general anesthesia in combination with caudal block. Postoperative pain, hemodynamic parameters and total consumption of all medicaments in the perioperative period will be monitored. Complications and side effects of drugs will be observed as well.

Conditions

Interventions

TypeNameDescription
DRUGCaudal block with levobupivacaineAfter the introduction of general anesthesia, a single shot caudal block will be performed with levobupivacaine 0.25% (2.5 mg/kg; maximal dose 75 mg).
DRUGGeneral anesthesiaOn the day of operation all patients will recieve midazolam 0.5 mg/kg (maximum dose 15 mg) orally. Induction of anesthesia will be the same for all patients and consist of intravenous anesthetic propofol (2-3 mg/kg), opioid analgesic fentanyl (1-1.5 mcg/kg), and muscle relaxant rocuronium - bromide (0.6-1 mg/kg). The airway will be obtained by placing a laryngeal mask (I-gel®).
PROCEDUREInguinal hernioplastyElective inguinal hernioplasty

Timeline

Start date
2022-01-08
Primary completion
2024-07-20
Completion
2024-07-20
First posted
2023-07-24
Last updated
2024-12-04

Locations

1 site across 1 country: Serbia

Source: ClinicalTrials.gov record NCT05958589. Inclusion in this directory is not an endorsement.